VYRO BIO

Vyro is an immuno-oncology (I-O) biotechnology company developing cancer-killing, or ‘oncolytic’, viruses (OVs) designed to target adult and pediatric central nervous system (CNS) tumors, based on pioneering research and breakthrough discovery of the oncolytic properties of the Zika Virus (ZIKV).

#SimilarOrganizations #People #Financial #Website #More

VYRO BIO

Social Links:

Linkedin

Industry:

Biotechnology

Founded:

2021-02-25

Address:

São Paulo, Sao Paulo, Brazil

Country:

Brazil

Website Url:

http://www.vyrobio.com

Total Employee:

1+

Status:

Active

Contact:

5511984025024

Email Addresses:

[email protected]

Total Funding:

1.5 M USD

Similar Organizations

homology-medicines-logo

Homology Medicines

Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.

karma-biotechnologies-logo

Karma Biotechnologies

Karma Biotechnologies is solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform.

kytopen-logo

Kytopen

Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

passage-bio-logo

Passage Bio

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

Current Employees Featured

carolini-kaid_image

Carolini Kaid
Carolini Kaid CSO @ Vyro Bio
CSO
2021-02-25

Founder

carolini-kaid_image

Carolini Kaid

hugo-cabrera_image

Hugo Cabrera

Investors List

vesper-ventures-sa_image

Vesper Ventures SA

Vesper Ventures SA investment in Seed Round - Vyro Bio

Official Site Inspections

http://www.vyrobio.com

Host Informations
Whois Informations

Loading ...

More informations about "Vyro Bio" on Search Engine